David J Martyres1, Abi Vijenthira2, Nick Barrowman3, Sydney Harris-Janz4, Christine Chretien4, Robert J Klaassen4. 1. Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada. 2. Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. 3. Clinical Research Unit, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada. 4. Division of Hematology/Oncology, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.
Abstract
BACKGROUND: Sickle cell disease (SCD) is characteristically described as a disease of hemolytic anemia and vaso-occlusive crises (VOCs). However, patients suffer from a multitude of other problems including impaired development, chronic pain, and increased susceptibility to infection. Nutritional deficiency has been implicated as a contributor to these issues. PROCEDURE: We reported the nutrition status with respect to vitamin D, zinc, B6, B12, folate, and homocysteine serum levels in Canadian children with SCD (n = 91). We also tested for associations between nutrients and markers of disease severity and growth. RESULTS: Almost half the sample (42%) had multiple nutrient insufficiencies/deficiencies, and a further 27% had a single insufficiency/deficiency. The most common insufficiency/deficiency was zinc in 57% followed by calcidiol (25 dihydroxyvitamin D (25(OH)D)) (52%). Sixteen percent of patients had low vitamin B6 levels, while folate, calcitriol (1,25(OH)D), and homocysteine levels were normal. Increased number of vitamin insufficiencies/deficiencies was associated with increasing disease severity (P = 0.018). Zinc insufficiency/deficiency was significantly associated with an increased number of home pain crises (P = 0.001) and an increased incidence of hospitalizations for VOCs (P = 0.01). CONCLUSIONS: Our findings show that patients with SCD commonly have multiple nutrient insufficiencies/deficiencies and support the growing evidence for the link between low zinc and increased VOC. It also indicates that increased nutrient insufficiencies/deficiencies are associated with increased disease severity in SCD. Prospective studies with larger samples are needed to further elucidate the relationship between nutrient deficiencies and SCD, and to determine whether nutrient supplementation can improve the disease course.
BACKGROUND:Sickle cell disease (SCD) is characteristically described as a disease of hemolytic anemia and vaso-occlusive crises (VOCs). However, patients suffer from a multitude of other problems including impaired development, chronic pain, and increased susceptibility to infection. Nutritional deficiency has been implicated as a contributor to these issues. PROCEDURE: We reported the nutrition status with respect to vitamin D, zinc, B6, B12, folate, and homocysteine serum levels in Canadian children with SCD (n = 91). We also tested for associations between nutrients and markers of disease severity and growth. RESULTS: Almost half the sample (42%) had multiple nutrient insufficiencies/deficiencies, and a further 27% had a single insufficiency/deficiency. The most common insufficiency/deficiency was zinc in 57% followed by calcidiol (25 dihydroxyvitamin D (25(OH)D)) (52%). Sixteen percent of patients had low vitamin B6 levels, while folate, calcitriol (1,25(OH)D), and homocysteine levels were normal. Increased number of vitamin insufficiencies/deficiencies was associated with increasing disease severity (P = 0.018). Zinc insufficiency/deficiency was significantly associated with an increased number of home pain crises (P = 0.001) and an increased incidence of hospitalizations for VOCs (P = 0.01). CONCLUSIONS: Our findings show that patients with SCD commonly have multiple nutrient insufficiencies/deficiencies and support the growing evidence for the link between low zinc and increased VOC. It also indicates that increased nutrient insufficiencies/deficiencies are associated with increased disease severity in SCD. Prospective studies with larger samples are needed to further elucidate the relationship between nutrient deficiencies and SCD, and to determine whether nutrient supplementation can improve the disease course.
Authors: Joseph K Sungu; Olivier Mukuku; Augustin Mulangu Mutombo; Paul Mawaw; Michel N Aloni; Oscar N Luboya Journal: J Clin Lab Anal Date: 2017-02-15 Impact factor: 2.352
Authors: Cristina R Fernández; Maureen Licursi; Randi Wolf; Margaret T Lee; Nancy S Green Journal: Pediatr Blood Cancer Date: 2021-11-22 Impact factor: 3.167
Authors: Anna M Hood; Charles T Quinn; Christopher D King; Lisa M Shook; James L Peugh; Lori E Crosby Journal: Complement Ther Med Date: 2020-02-15 Impact factor: 2.446
Authors: Brock A Williams; Heather McCartney; Erin Adams; Angela M Devlin; Joel Singer; Suzanne Vercauteren; John K Wu; Crystal D Karakochuk Journal: Trials Date: 2020-06-29 Impact factor: 2.279
Authors: Shahida A Khan; Ghazi Damanhouri; Ashraf Ali; Sarah A Khan; Aziz Khan; Ahmed Bakillah; Samy Marouf; Ghazi Al Harbi; Saeed H Halawani; Ahmad Makki Journal: Nutr Metab (Lond) Date: 2016-08-08 Impact factor: 4.169
Authors: Kaitlyn L I Samson; Heather McCartney; Suzanne M Vercauteren; John K Wu; Crystal D Karakochuk Journal: J Clin Med Date: 2018-01-30 Impact factor: 4.241